These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15713873)

  • 21. Drug Insight: angiotensin-converting-enzyme inhibitors and atrial fibrillation--indications and contraindications.
    Lévy S
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):220-5. PubMed ID: 16568131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systolic heart failure: no room for complacency.
    Jackson G
    Int J Clin Pract; 2000 Jun; 54(5):279-80. PubMed ID: 10954952
    [No Abstract]   [Full Text] [Related]  

  • 23. Focale: study of systolic and diastolic heart failure in a French elderly population.
    Dubourg O; Gueret P; Beauchet A; Nisse-Durgeat S; Ducardonnet A
    Int J Cardiol; 2008 Feb; 124(2):188-92. PubMed ID: 17399824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapy for diastolic heart failure: on the road from myths to multicenter trials.
    Kitzman DW
    J Card Fail; 2001 Sep; 7(3):229-31. PubMed ID: 11561222
    [No Abstract]   [Full Text] [Related]  

  • 25. Heart disease and aging.
    Aronow WS
    Med Clin North Am; 2006 Sep; 90(5):849-62. PubMed ID: 16962846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
    Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
    Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical trials, the renin angiotensin system and atrial fibrillation.
    Birnie DH; Gollob M; Healey JS
    Curr Opin Cardiol; 2006 Jul; 21(4):368-75. PubMed ID: 16755207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening.
    Wang TJ; Levy D; Benjamin EJ; Vasan RS
    Ann Intern Med; 2003 Jun; 138(11):907-16. PubMed ID: 12779301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of heart failure.
    Le Jemtel TH
    Curr Cardiol Rep; 2000 May; 2(3):221-4. PubMed ID: 10980896
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of congestive heart failure: how well are we doing?
    Giannetti N
    CMAJ; 2001 Aug; 165(3):305-6. PubMed ID: 11517648
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapeutic aims for atrial fibrillation in patients with heart failure].
    Lewalter T; Nitschmann S
    Internist (Berl); 2009 Jan; 50(1):101-3. PubMed ID: 19137270
    [No Abstract]   [Full Text] [Related]  

  • 32. Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation.
    Anand K; Mooss AN; Hee TT; Mohiuddin SM
    Am Heart J; 2006 Aug; 152(2):217-22. PubMed ID: 16875900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
    Weir R; McMurray JJ
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heart failure: do we deliver quality care?
    Jain MK; Butler J; Mirvis DM
    Tenn Med; 2003 Feb; 96(2):81-4. PubMed ID: 12645367
    [No Abstract]   [Full Text] [Related]  

  • 35. Left ventricular dysfunction in atrial fibrillation: restoration of sinus rhythm by the Cox-maze procedure significantly improves systolic function and functional status.
    Stulak JM; Dearani JA; Daly RC; Zehr KJ; Sundt TM; Schaff HV
    Ann Thorac Surg; 2006 Aug; 82(2):494-500; discussion 500-1. PubMed ID: 16863752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in notions about heart failure.
    Petrie M; McMurray J
    Lancet; 2001 Aug; 358(9280):432-4. PubMed ID: 11513900
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevalence, prognostic significance, and treatment of atrial fibrillation in congestive heart failure with particular reference to the DIAMOND-CHF study.
    Pedersen OD; Brendorp B; Køber L; Torp-Pedersen C
    Congest Heart Fail; 2003; 9(6):333-40. PubMed ID: 14688506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination therapy of renin angiotensin system inhibitors and bepridil is useful for maintaining sinus rhythm in patients with atrial fibrillation.
    Kawamura M; Ito H; Onuki T; Miyoshi F; Minoura Y; Asano T; Tanno K; Kobayashi Y
    J Cardiol; 2007 Dec; 50(6):343-50. PubMed ID: 18186308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation.
    Lip GY; Frison L; Grind M
    J Intern Med; 2007 Jun; 261(6):577-86. PubMed ID: 17547713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials.
    Phillips CO; Kashani A; Ko DK; Francis G; Krumholz HM
    Arch Intern Med; 2007 Oct; 167(18):1930-6. PubMed ID: 17923591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.